New role of platelets in schizophrenia: predicting drug response
Background Elevated platelet count (PLTc) is associated with first-episode schizophrenia and adverse outcomes in individuals with precursory psychosis. However, the impact of antipsychotic medications on PLTc and its association with symptom improvement remain unclear.Aims We aimed to investigate ch...
Saved in:
Main Authors: | Tao Li, Wei Wei, Qiang Wang, Yamin Zhang, Wei Deng, Rui Xue, Wanjun Guo, Xiaojing Li, Hua Yu, Yanghao Zheng, Peiyan Ni, Sugai Liang, Xueyu Qi, Xueli Yu, Liansheng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-04-01
|
Series: | General Psychiatry |
Online Access: | https://gpsych.bmj.com/content/37/2/e101347.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metformin for neurocognitive dysfunction in schizophrenia: a systematic review
by: Zhen-Juan Qin, et al.
Published: (2025-01-01) -
Individualized prediction of multi-domain intelligence quotient in bipolar disorder patients using resting-state functional connectivity
by: Xiaoyu Li, et al.
Published: (2025-03-01) -
Peripheral tryptophan-kynurenine pathway dysfunction in first-episode schizophrenia
by: Mian Li, et al.
Published: (2025-01-01) -
Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk
by: Wenxi Sun, et al.
Published: (2025-01-01) -
Eccentric indices based QSPR evaluation of drugs for schizophrenia treatment
by: Muneeba Mansha, et al.
Published: (2025-01-01)